Trials / Conditions / Recurrent Undifferentiated Pleomorphic Sarcoma
Recurrent Undifferentiated Pleomorphic Sarcoma
4 registered clinical trials studyying Recurrent Undifferentiated Pleomorphic Sarcoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleo NCT05017103 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable NCT03307616 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma NCT02601209 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Alisertib in Treating Patients With Advanced or Metastatic Sarcoma NCT01653028 | National Cancer Institute (NCI) | Phase 2 |